3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
2
Thrombocythemia, Essential
1
Stomatitis
1
Stomach Neoplasms
1
Radiation Pneumonitis
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Glioblastoma
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Chemotherapy-Related Cognitive Impairment
1
Breast Neoplasms
1
Attention Deficit Disorder with Hyperactivity
1
Acute Kidney Injury
1
Interventions
Cyclophosphamide
6
Vincristine
3
Temozolomide
3
Radiotherapy
3
Cisplatin
3
Automobiles
3
fludarabine
2
Etoposide
2
Eflornithine
2
Carboplatin
2
omburtamab I-131
1
ibrutinib
1
gallium Ga 68 dotatate
1
etoposide phosphate
1
belzutifan
1
Zoledronic Acid
1
Thiotepa
1
Tamoxifen
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Pemetrexed
1
ONC206
1
Nivolumab
1
Mesna
1
Maintenance Chemotherapy
1
Lomustine
1
Isotretinoin
1
Induction Chemotherapy
1
Hydrocortisone
1
HhAntag691
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Acetylcysteine
×
1 year
×
Clear all
No trials found.